Skip to content

The Effect of narrative writing on depression, anxiety and stress

Determination of the Effect of Narrative writing on Maternal Depression, Anxiety and Stress in women referring to Prenatal care units of Tehran University Of Medical Sciences

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170815035722N2
Enrollment
120
Registered
2018-03-04
Start date
2018-02-24
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: depression. Condition 2: anxiety. Condition 3: stress. Major depressive disorder, single episode, mild Generalized anxiety disorder Adjustment disorders

Interventions

Intervention 1: Intervention group: The narrative writing group that follows the instructions should write two times a week for two months about their deep thoughts and feelings about pregnancy, fetus

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Pregnant women with gestational age between 25 and 28 weeks age between 18 and 45 years old Having literacy and ability to read and write Not taking drugs that cause depression (such as Anti-epileptic drugs, Anti hypertensive drugs, Corticosteroids, Digoxin, Diuretics, Potent tranquilizers, Anti-Parkinson agents) Singleton pregnancy Being Primiparous Having a telephone number Wanted pregnancy Earning score of 10-17 (mild depression) from Beck Depression questionnaire mild depression, mild to medium anxiety, mild to medium stress from DASS21 questionnaire

Exclusion criteria

Exclusion criteria: Change of location Stressful events during the study (Death of a close Relative, spouse, newborn, economic problems, marital problems and divorce) Intrauterine Fetal Death in current pregnancy preterm laber Death of mother Unwillingness to continue the study for any reason Narrative writing less than twice a week Having chronic illness Having diseases that cause depression (such as Epilepsy, Migraine, Multiple Sclerosis) Taking psychotropic drugs (Opium, Crack, Heroin, Cigarette) Fetal Anomaly in current oregnancy Abortion history

Design outcomes

Primary

MeasureTime frame
Depression. Timepoint: Before intervention, 4 weeks after intervention, 8 weeks after intervention. Method of measurement: DASS21 Questionnaire (depression-anxiety and stress).;Anxiety. Timepoint: Before intervention, 4 weeks after intervention, 8 weeks after intervention. Method of measurement: DASS21 questionnaire (depression-anxiety and stress).;Stress. Timepoint: Before intervention, 4 weeks after intervention, 8 weeks after intervention. Method of measurement: DASS21 questionnaire (depression-anxiety and stress).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Khalili

Tehran University Of Medical Sciences, School Of Nursing And Midwifery

nedakhalili1370@yahoo.com+98 21 6692 7171

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026